Cardiometabolic Health and Diabetes
Mark your calendars now to experience the premiere global event focusing on improving health by championing scientific discovery and practice-changing educational content.
Begin your #AHA22 experience by submitting an abstract April 13 – June 9, 6:00 PM CST. We can’t wait to see you this November!
Even though #AHA21 was fully virtual, our flagship meeting brought us together across the globe. If you missed some of our great programming, now is your chance!
Members and attendees can now access informative, practice-changing sessions or earn CE credits for free -- through a different link. And nonmembers can purchase our Sessions package or our special CE bundle.
The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.
The Council on Lifestyle and Cardiometabolic Health promotes the expansion and exchange of knowledge with the ultimate goal of improving cardiovascular health across the lifespan. The council nurtures basic, clinical, epidemiological, and translational science related to nutrition, lipids, obesity, diabetes, physical activity, and behavioral change.
FIDELIO DKD Results
Investigator Gerasimos Filippatos, MD summarizes the results of FIDELIO-DKD, which examined whether finerenone affected cardiovascular outcomes in patients with chronic kidney disease and T2DM.